Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Acrylic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dimethyl Sulfoxide SCHEMBL7058096 | 0.81 | LMNA (0.37) | — | |
| Acrylic Acid SCHEMBL30476491 | 0.79 | LMNA (0.83) | — | |
| Acrylic Acid SCHEMBL21834318 | 0.79 | LMNA (0.83) | — | |
| Acrylic Acid SCHEMBL30456235 | 0.79 | LMNA (0.83) | — | |
| Acrylic Acid SCHEMBL5516210 | 0.79 | LMNA (0.83) | — | |
| Acrylic Acid SCHEMBL23460306 | 0.79 | LMNA (0.83) | — | |
| Acrylic Acid SCHEMBL29703187 | 0.79 | — | — | |
| Acrylic Acid SCHEMBL2464737 | 0.79 | — | — | |
| Acrylic Acid SCHEMBL10945024 | 0.79 | LMNA (0.83) | — | |
| Acrylic Acid SCHEMBL1682387 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10799600-B1 | Targeted nanoparticles | NANODERM SCIENCES, INC. (US) | 2020-10-13 | — | — | US | disclosed |
| US-20180325820-A1 | BIOCOMPATIBLE WATER-SOLUBLE POLYMERS INCLUDING SULFOXIDE FUNCTIONALITY | CARNEGIE MELLON UNIVERSITY | 2018-11-15 | — | — | US | disclosed |
| CN-108276549-A | The preparation method of modified aqueous polyurethane | 苏州浩洋聚氨酯科技有限公司 | 2018-07-13 | — | — | CN | disclosed |
| US-20180028684-A1 | TARGETED NANOPARTICLES | NANODERM SCIENCES, INC. (US) | 2018-02-01 | — | — | US | disclosed |
| US-9694085-B2 | Targeted therapeutic nanoparticles | NANODERM SCIENCES, INC. (US) | 2017-07-04 | — | — | US | disclosed |
| EP-2872120-B1 | THERAPEUTIC NANOPARTICLES WITH A POLYMYXIN B AS TARGETING AGENT | NANODERM SCIENCES INC (US) | 2017-05-03 | — | — | EP | disclosed |
| US-20160106852-A1 | TARGETED THERAPEUTIC NANOPARTICLES | NANODERM SCIENCES, INC. (US) | 2016-04-21 | — | — | US | disclosed |
| US-9161962-B2 | Targeted therapeutic nanoparticles | NANODERM SCIENCES, INC. (US) | 2015-10-20 | — | — | US | disclosed |
| EP-2872120-A1 | TARGETED THERAPEUTIC NANOPARTICLES | Nanoderm Sciences, Inc. (US) | 2015-05-20 | — | — | EP | disclosed |
| US-20140199232-A1 | Targeted Therapeutic Nanoparticles | NANODERM SCIENCES, INC. (US) | 2014-07-17 | — | — | US | disclosed |
| WO-2014014890-A1 | TARGETED THERAPEUTIC NANOPARTICLES | NANODERM SCIENCES, INC. (US) | 2014-01-23 | — | — | WO | disclosed |